Julie Lellouche, Author at Labiotech.eu

About

Blogger for Labiotech.eu. Entrepreneurial Student at SupBiotech, Paris Higher Biotechnology Institute.

Articles by Julie Lellouche

News and Trends 30 Sep 2014

New Collaboration for New Cancer Therapies

Medimmune, the global biologics research and development arm of Anglo-Swedish drug major AstraZeneca, has entered into a collaboration to establish a joint lab in Cambridge, UK, with Cancer Research Technology, the commercial arm of Cancer Research UK. The new laboratory will be the first partnership of its kind of both organizations, and will focus on […]

September 30, 2014 - 2 minutesmins - By Julie Lellouche

News and Trends 29 Sep 2014

How to Save Thousands of Lives Thanks to Tuberculosis Test Fitting in your Pocket?

The EU-funded POCKET project is developing a low-cost urine test that can quickly detect tuberculosis (TB), a preventable disease that kills nearly 2 million people every year. Started in November 2013, the initiative already started and develops a low-cost urine test that will make TB detection accessible to all. Right now, researchers working on POCKET […]

September 29, 2014 - 2 minutesmins - By Julie Lellouche

News and Trends 26 Sep 2014

An Innovative Test to Detect Colon Cancer on Time

The AIT Austrian Institute of Technology, BioVendor and SCIENION today announced that the three organizations will partner on the development of an in-vitro diagnostic test for colon cancer. The innovative test kit shall identify cancer at an early stage based on tumor autoantibody biomarkers. The three structures will work closely together to develop the in-vitro diagnostic test […]

September 26, 2014 - 2 minutesmins - By Julie Lellouche

News and Trends 25 Sep 2014

A New Financial Hope for Start-ups Focused on Cancer

Aglaia is a new venture capital fund that will invest in about ten to fifteen biotechnology start-ups developing groundbreaking technologies to prevent and cure cancer. The Dutch venture has announced the launch of Aglaia Oncology Fund II. Investors contribute with $65M (EUR 51M) for the fund, to reach $80M (EUR 63M) to $100M (EUR 80M). Like […]

September 25, 2014 - 2 minutesmins - By Julie Lellouche

Kao research identifies natural enzyme to produce sustainable surfactants strict xxl

News and Trends 24 Sep 2014

Natural Cosmetics thanks to Enzymes?

A 7 million euros European-funded project has been launched with the intention of replacing chemical cosmetic production techniques with eco-friendly alternatives. This is the OPTIBIOCAT project which wants to provide technical improvement to the natural cosmetics sector, required to satisfy consumer demand for natural and ecological products. Building on a diverse consortium of 16 partners from […]

September 24, 2014 - 2 minutesmins - By Julie Lellouche

Sophia Genetics is the first European bioinformatic company allowed to analyze clinical genetic data

News and Trends 17 Sep 2014

Sophia Genetics: the first European bioinformatic company allowed to analyze clinical genetic data

Sophia Genetics has become the first European company to obtain a CE-IVD mark allowing the use of their bioinformatic algorithms to analyse clinical data obtained through Next Generation Sequencing. This certification is an important step in making these in the standard use of routine genetic testing and clinical diagnosis. It brings Sophia Genetics’ world-leading Data Driven Medicine platform to […]

September 17, 2014 - 2 minutesmins - By Julie Lellouche

Eli Lilly and Boehringer Ingelheim’s product the first insulin biosimilar approved in Europe2

News and Trends 16 Sep 2014

The first insulin biosimilar has been approved in Europe

The European Commission granted marketing authorisation to Eli Lilly and Company and Boehringer Ingelheim for the first insulin biosimilar glargine product. It is indicated to treat diabetes in adults, adolescents and children aged 2 years and above. The collaboration between the two companies is bearing fruit, it is the first-ever version of this class. It received […]

September 16, 2014 - 2 minutesmins - By Julie Lellouche

News and Trends 1 Sep 2014

Fighting prostate cancer with a tomato-rich diet

Men who eat over 10 portions a week of tomatoes have an 18 per cent lower risk of developing prostate cancer, new research suggests. With 35,000 new cases every year in the UK, and around 10,000 deaths, prostate cancer is the second most common cancer in men worldwide. Rates are higher in developed countries, which […]

September 1, 2014 - 3 minutesmins - By Julie Lellouche

News and Trends 31 Aug 2014

Why should you drink tea instead of coffee?

Drinking tea reduces non-cardiovascular mortality by 24%, reveals a study in 131 000 people presented at ESC Congress today by Professor Nicolas Danchin from France. Professor Danchin said: “If you have to choose between tea or coffee it’s probably better to drink tea. Coffee and tea are important components of our way of life. Their […]

August 31, 2014 - 4 minutesmins - By Julie Lellouche

Resources

Categories

The twelve hottest biotech companies in the Boston area

Biotech bankruptcies: what to expect in 2024 following a record year?

Approaches

Therapeutic areas

RNA editing set to take off: could it outperform gene editing?

Future of cancer treatment: what will therapy look like in 2034?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us